Catalyst Wire Dossier Catalyst Wire Dossier

Lpathomab

· Lpath, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lpathomab, covering 2016-05-06 to 2016-05-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers [Phase 1]

See pricing